First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

NCT01284205 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped This indication is not being pursued at this point in time.

Conditions

Bladder Cancer

Interventions

BIOLOGICAL: Mycobacterial Cell-Wall DNA Complex
BIOLOGICAL: Bacillus Calmette-Guerin

Sponsor

Bioniche Life Sciences Inc.